De novo mutations in KCNQ2 also cause epileptic encephalopathy (EE), which is characterized by persistent seizures that are often drug refractory, neurodevelopmental delay, and intellectual disability. This evidence concerns the gene KCNQ2 and Epileptic encephalopathy.